```
prompt_version: stage1-v15-20260331

target_title:   Palladium-catalyzed enantioselective Heck alkenylation of trisubstituted allylic alkenols: a redox-relay strategy to construct vicinal stereocenters
target_authors: Chun Zhang, Brandon Tutkowski, Ryan J. DeLuca, Leo A. Joyce, Olaf Wiest, Matthew S. Sigman
target_start:   page 2277: [REDACTED: paper boundary quote; see Tier 9]
target_end:     end of document

[Turn 1: Agent V1]
field: Asymmetric transition-metal catalysis (enantioselective Pd-catalyzed C-C bond formation, redox-relay Heck reactions)
field_rationale: BIB-3 (Chemical Science) and BIB-1 (Pd-catalyzed enantioselective Heck alkenylation) place the paper in asymmetric organometallic catalysis; S0-4 specifies Pd/PyrOx catalysis, DFT transition-state analysis, and enantioselectivity measurement by SFC/HPLC as the core methodology.

V1-Q1
loc: P2279, Table 2 caption*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Absolute configuration is independently confirmed for only one product (3d). For the remaining 10 alkenol-scope products (3a–3c, 3e–3k) and 15 triflate-scope products (3m–3y), configuration is assigned by structural analogy. For substrates bearing different substitution patterns, ring sizes, or heteroatom substituents (e.g., lactone-derived 3r, phthalimide-containing 3v, natural-product-derived 3w–3y), what evidence beyond analogy to 3d supports the stereoassignment?
severity: high
inference_tier: T1

V1-Q2
loc: P2278, Table 1 caption*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The optimization table (Table 1) reports dr for entries 1–6 and 8–10 as ">20:1" — a lower bound only. What is the actual dr for the optimized conditions, and how was dr measured (NMR, SFC, or HPLC)? The method for dr determination is not stated anywhere in the paper.
severity: medium
inference_tier: T1

V1-Q3
loc: P2278, "Results and discussion"*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Catalyst loading (mol% of Pd₂(dba)₃ and PyrOx ligand), reaction temperature, and reaction time are not stated in the main text of the optimization section. These parameters appear only in ESI. For independent replication of the key results, what are the full standard conditions?
severity: medium
inference_tier: T1

V1-Q4
loc: P2278, Scheme 1C*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Two mechanistically distinct oxidation pathways are proposed for the alcohol-to-ketone step (β-hydride elimination from 7 vs. E2-type elimination), but no experiment or observation distinguishes between them. What evidence selects one pathway over the other, and does the choice affect the diastereochemical outcome?
severity: high
inference_tier: T1

V1-Q5
loc: P2279, Scheme 2*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Intermediates 8–10 in the cyclopropyl ring-opening cascade are proposed but not experimentally detected (no deuterium labeling, crossover experiment, or trapping of intermediates is reported). What evidence beyond the structure of the isolated product 3l supports this specific mechanistic sequence?
severity: medium
inference_tier: T1

V1-Q6
loc: P2280, Table 3*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: (E)-to-(Z)-triflate isomerization under the reaction conditions is invoked to explain the product er pattern, but no direct evidence (e.g., monitoring the triflate composition by NMR before or during reaction) is provided. Was triflate isomerization directly observed, or is it inferred solely from the product er values?
severity: high
inference_tier: T1

V1-Q7
loc: P2278, "Results and discussion"*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The NBO charge–enantioselectivity correlation is relegated to ESI. How many solvents are included in the correlation, what is the R² value, and does the correlation hold predictively (i.e., was a new solvent predicted and then tested)? Relegating this mechanistic model to ESI prevents evaluation of its predictive validity.
severity: medium
inference_tier: T1

V1-Q8
loc: P2280, Table 4*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The dramatic yield drop (31%) and er erosion (89:11 vs. 95:5) for the homoallylic substrate 2z are attributed to the system being "optimized for allylic substrates," but the structural or mechanistic reason for this selectivity is not analyzed. Was the reaction time extended, concentration varied, or alternative ligands screened for 2z?
severity: medium
inference_tier: T2 [paper-grounded inference]

V1-Q9
loc: P2279, Table 2*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The alkenol scope (Table 2, 11 substrates) and triflate scope (Table 3, 15 substrates) contain no substrates bearing common functional groups such as free NH, ester, ether, halide, or nitro substituents. Was functional group tolerance tested and found incompatible, or were such substrates not attempted?
severity: medium
inference_tier: T2 [paper-grounded inference]

V1-Q10
loc: P2278, Scheme 1C*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Regioselectivity of the migratory insertion — alkenyl addition distal to the alcohol — is stated as a known propensity but no experiment in this paper independently confirms regioselectivity (e.g., using a symmetrically substituted alkenol or a deuterium-labeled substrate). Was regiochemistry verified for any substrate in this study independently of the proposed mechanism?
severity: medium
inference_tier: T2 [paper-grounded inference]

V1-Q11
loc: P2278, Table 1*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: No control experiment using racemic (achiral) Pd catalyst or no ligand is reported to confirm that the observed enantioselectivity arises from the chiral PyrOx ligand rather than from inherent substrate-controlled selectivity with the specific alkene geometry.
severity: medium
inference_tier: T2 [paper-grounded inference]

V1-Q12
loc: P2280, Table 4*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: For (Z)-alkenol 2aa (57:43 er), the paper uses DFT to explain the low selectivity but does not report whether alternative ligands, solvents, or temperatures were examined to improve the er. Is this substrate genuinely incompatible with high enantioselectivity, or is the optimization for the (Z)-geometry unexplored?
severity: medium
inference_tier: T2 [paper-grounded inference]

V1-Q13
loc: P2279–2280, Tables 3 and 4*
quote: [REDACTED: substantial verbatim quotation; see Tier 9] (Table 3, footnote b); [REDACTED: verbatim source quotation; see `loc:`] (Table 3, footnote c)
question: For chiral triflate substrates 1w–1y (nootkatone, estrone, cholesterol), the (R)-t-BuPyrOx ligand is used rather than the standard (S)-PyrOx, but the basis for this ligand choice is relegated to ESI. What rationale — matched/mismatched pair analysis, preliminary er comparison — governs the ligand selection for each chiral substrate?
severity: medium
inference_tier: T1

V1-Q14
loc: P2282, Conclusions*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: "No or little observed epimerization" is qualified in the abstract as "no observed epimerization" but in the conclusions as "no or little." Which is accurate, and was epimerization specifically tested (e.g., by comparison of er of freshly isolated product versus product after prolonged exposure to base or acid)?
severity: high
inference_tier: T1

V1-Q15
loc: P2282, Conclusions*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: No synthesis of a complex target or demonstration of the reaction's utility in a multi-step sequence is presented, despite the paper's framing of vicinal stereocenter construction as strategically valuable. The biological/pharmaceutical relevance of the alkyl vinyl ketone products (3a–3k) is not illustrated.
severity: low
inference_tier: T2 [paper-grounded inference]
```

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
